Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Best practices for metabolite quantification in drug development: updated recommendation from the European Bioanalysis Forum.

Timmerman P, Blech S, White S, Green M, Delatour C, McDougall S, Mannens G, Smeraglia J, Williams S, Young G.

Bioanalysis. 2016 Jun;8(12):1297-305. doi: 10.4155/bio-2016-0103. Epub 2016 May 24.

2.

The metabolism and disposition of the oral dipeptidyl peptidase-4 inhibitor, linagliptin, in humans.

Blech S, Ludwig-Schwellinger E, Gräfe-Mody EU, Withopf B, Wagner K.

Drug Metab Dispos. 2010 Apr;38(4):667-78. doi: 10.1124/dmd.109.031476. Epub 2010 Jan 19.

PMID:
20086031
3.

The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans.

Blech S, Ebner T, Ludwig-Schwellinger E, Stangier J, Roth W.

Drug Metab Dispos. 2008 Feb;36(2):386-99. Epub 2007 Nov 15.

PMID:
18006647

Supplemental Content

Support Center